Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 4.05 · gapped below the open, then crossed back over prior close. High/low 4.11 at 3:15 pm ET, 3.09 at 9:00 am ET.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“To support our research efforts, we have partnered with academic experts at Johns Hopkins University for ALS, the University of Cambridge for myelination-related experiments, Northwestern University for myelination-related experiments, George Washington University for myelination-related experiments, and the University of Edinburgh for myelination-related research.”
FILING10-K0001437749-26-008502cik 0001822791
“To support our research efforts, we have partnered with academic experts at Johns Hopkins University for ALS, the University of Cambridge for myelination-related experiments, Northwestern University for myelination-related experiments, George Washington University for myelination-related experiments, and the University of Edinburgh for myelination-related research.”
FILING10-K0001437749-26-008502cik 0001822791
“To support our research efforts, we have partnered with academic experts at Johns Hopkins University for ALS, the University of Cambridge for myelination-related experiments, Northwestern University for myelination-related experiments, George Washington University for myelination-related experiments, and the University of Edinburgh for myelination-related research.”
FILING10-K0001437749-26-008502cik 0001822791
“To support our research efforts, we have partnered with academic experts at Johns Hopkins University for ALS, the University of Cambridge for myelination-related experiments, Northwestern University for myelination-related experiments, George Washington University for myelination-related experiments, and the University of Edinburgh for myelination-related research.”
FILING10-K0001437749-26-008502cik 0001822791
“To support our research efforts, we have partnered with academic experts at Johns Hopkins University for ALS, the University of Cambridge for myelination-related experiments, Northwestern University for myelination-related experiments, George Washington University for myelination-related experiments, and the University of Edinburgh for myelination-related research.”
FILING10-K0001437749-26-008502cik 0001822791
“REPAIR-MS was conducted at the University of Texas Southwestern, a center with specialized capabilities for conducting and analyzing 7T 31 P-MRS imaging studies, and was conducted in conjunction with our REPAIR-PD trial (discussed below), with pre-specified integrated analyses of both REPAIR-MS Cohort 1 and REPAIR-PD trials performed.”
FILING10-K0001437749-26-008502cik 0001822791
“We paid Canaccord a placement agent fee of 6.00% of the aggregate gross proceeds of the offering.”
FILING10-K0001437749-26-008502cik 0001822791
“We also received indirect financial support for the HEALEY ALS Platform Trial, administered by Massachusetts General Hospital, which conducted an ALS platform trial of CNM-Au8 alongside multiple other drug candidates, at significantly lower costs than we would have otherwise incurred if we had conducted a comparably designed clinical trial at reasonable market rates.”
FILING10-K0001437749-26-008502cik 0001822791
“We are still actively supporting: (i) a long-term OLE for RESCUE-ALS, (ii) a compassionate-use EAP ("EAP01") launched in partnership with the Sean M. Healey & AMG Center ("Healey Center") for ALS at Massachusetts General Hospital, (iii) a second EAP ("EAP02") launched in partnership with Massachusetts General Hospital that includes centers across the United States ("U.S."), and (iv) an EAP (the "ACT-EAP") funded by a four-year grant from the National Institute of Neurological Disorders and Stroke ("NINDS"), a division of the National Institutes of Health ("NIH"), that is being conducted in collaboration with New York University ("NYU") and Synapticure, a neurology specialty telehealth clinic.”
FILING10-K0001437749-26-008502cik 0001822791
“We contributed a direct fee to the Healey Center toward the clinical conduct of the trial and there were no additional licensing fees or milestone requirements.”
FILING10-K0001437749-26-008502cik 0001822791
“Panel C, the rate of decay of the NADH absorbance peak is greater for CNM-Au8 than it is for citrate-reduced gold, nanoparticles of 10 nm (orange) and 30 nm (red) diameters (purchased from the National Institute of Standards and Technology), indicating that CNM-Au8 has a catalytic rate at least three-fold higher than National Institute of Standards and Technology comparators under the same reaction conditions.”
FILING10-K0001437749-26-008502cik 0001822791
“We are still actively supporting: (i) a long-term OLE for RESCUE-ALS, (ii) a compassionate-use EAP ("EAP01") launched in partnership with the Sean M. Healey & AMG Center ("Healey Center") for ALS at Massachusetts General Hospital, (iii) a second EAP ("EAP02") launched in partnership with Massachusetts General Hospital that includes centers across the United States ("U.S."), and (iv) an EAP (the "ACT-EAP") funded by a four-year grant from the National Institute of Neurological Disorders and Stroke ("NINDS"), a division of the National Institutes of Health ("NIH"), that is being conducted in collaboration with New York University ("NYU") and Synapticure, a neurology specialty telehealth clinic.”
FILING10-K0001437749-26-008502cik 0001822791
“Panel A, SOD-like activity of CNM-Au8 on superoxide radicals was measured using a colorimetric SOD assay kit (Cayman Chemical).”
FILING10-K0001437749-26-008502cik 0001822791
Watchlist prices, news filtered to it, and its next report on your desk.
Clene Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Clene Inc. has 13 disclosed suppliers and 0 disclosed customers. Each one is named in an SEC filing, either Clene Inc.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
No filing we have read names a customer of Clene Inc.. Customers appear here when Clene Inc. names them, or when a company names Clene Inc. as a supplier in its own annual report.
CLNN (Clene Inc.) has 13 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.